Indeed, they synthesize cationic polymeric liposomes composed of an EGF derivative (EGF-GHDC), cholesterol, and DOPE, for the systemic delivery of the p53 gene to ovarian cancer cells with high efficiency [208]. The gene discussed is EGF; the disease is ovarian cancer.